52 related articles for article (PubMed ID: 8752731)
21. Monitoring of minimal residual disease in leukemia, advantages and pitfalls.
Cazzaniga G; Gaipa G; Rossi V; Biondi A
Ann Med; 2006; 38(7):512-21. PubMed ID: 17101542
[TBL] [Abstract][Full Text] [Related]
22. Detection of minimal residual disease in acute leukemia.
van der Velden VH; Boeckx N; van Wering ER; van Dongen JJ
J Biol Regul Homeost Agents; 2004; 18(2):146-54. PubMed ID: 15471219
[TBL] [Abstract][Full Text] [Related]
23. Detection and monitoring of minimal residual disease by quantitative real-time PCR.
Schüler F; Dölken G
Clin Chim Acta; 2006 Jan; 363(1-2):147-56. PubMed ID: 16154122
[TBL] [Abstract][Full Text] [Related]
24. The detection and significance of minimal residual disease in acute and chronic leukemia.
Chung NG; Buxhofer-Ausch V; Radich JP
Tissue Antigens; 2006 Nov; 68(5):371-85. PubMed ID: 17092250
[TBL] [Abstract][Full Text] [Related]
25. [Detection of minimal residual disease in children leukemia patients by using PCR - review].
He YY; Ye TZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):652-6. PubMed ID: 17605887
[TBL] [Abstract][Full Text] [Related]
26. Polymerase chain reaction (PCR) approach for the evaluation of minimal residual disease in acute leukemia.
Biondi A; Rambaldi A
Stem Cells; 1994 Jul; 12(4):394-401. PubMed ID: 7951006
[TBL] [Abstract][Full Text] [Related]
27. Minimal residual disease in hematologic malignancies.
San-Miguel JF; Bartram C; Campana D; Andreeff M
Rev Invest Clin; 1994 Apr; Suppl():147-52. PubMed ID: 7886299
[No Abstract] [Full Text] [Related]
28. Clinical significance of minimal residual disease in leukemia detected by polymerase chain reaction: is molecular remission a milestone for achieving a cure?
Ito Y; Miyamura K
Leuk Lymphoma; 1994 Dec; 16(1-2):57-64. PubMed ID: 7696932
[TBL] [Abstract][Full Text] [Related]
29. [The current status of genetic testing for leukemia].
Satoh Y; Masuda A; Yokota H; Yatomi Y
Rinsho Byori; 2014 Apr; 62(4):369-77. PubMed ID: 25022066
[TBL] [Abstract][Full Text] [Related]
30. [Detection of minimal residual leukemic cells in acute leukemia].
Irimajiri K
Rinsho Ketsueki; 1990 Apr; 31(4):409-15. PubMed ID: 2199697
[No Abstract] [Full Text] [Related]
31. Detection of minimal residual disease.
Dölken G
Adv Cancer Res; 2001; 82():133-85. PubMed ID: 11447762
[TBL] [Abstract][Full Text] [Related]
32. Techniques for detection of minimal residual disease.
Carlo-Stella C; Mangoni L; Dotti GP; Rizzoli V
Leuk Lymphoma; 1995; 18 Suppl 1():75-80. PubMed ID: 7496360
[TBL] [Abstract][Full Text] [Related]
33. [Molecular quantitation of minimal residual disease in leukemia].
Tamaki H; Ogawa H
Nihon Naika Gakkai Zasshi; 2003 Jun; 92(6):956-62. PubMed ID: 12866439
[No Abstract] [Full Text] [Related]
34. The polymerase chain reaction: a new tool for the detection of minimal residual disease in haematological malignancies.
Fey MF; Kulozik AE; Hansen-Hagge TE; Tobler A
Eur J Cancer; 1991; 27(1):89-94. PubMed ID: 1826449
[TBL] [Abstract][Full Text] [Related]
35. Detection of minimal residual disease in hematopoietic tissues.
Sharp JG; Bishop M; Chan WC; Greiner T; Joshi SS; Kessinger A; Reed E; Sanger W; Tarantolo S; Traystman M
Ann N Y Acad Sci; 1995 Dec; 770():242-61. PubMed ID: 8597365
[No Abstract] [Full Text] [Related]
36. Molecular evidence of minimal residual disease after treatment for leukaemia and lymphoma: an updated meeting report and review.
Potter MN; Cross NC; van Dongen JJ; Saglio G; Oakhill A; Bartram CR; Goldman JM
Leukemia; 1993 Aug; 7(8):1302-14. PubMed ID: 8350633
[TBL] [Abstract][Full Text] [Related]
37. Assessment of minimal residual disease in patients with acute leukemia.
Baer MR
Curr Opin Oncol; 1998 Jan; 10(1):17-22. PubMed ID: 9466480
[TBL] [Abstract][Full Text] [Related]
38. The use of the polymerase chain reaction for the detection of minimal residual malignant disease.
Negrin RS; Blume KG
Blood; 1991 Jul; 78(2):255-8. PubMed ID: 2070062
[No Abstract] [Full Text] [Related]
39. Detection of minimal residual disease in acute and chronic leukemias.
Radich J
Curr Opin Hematol; 1996 Jul; 3(4):310-4. PubMed ID: 9372093
[TBL] [Abstract][Full Text] [Related]
40. Detection of minimal residual disease in acute leukemia: methodologic advances and clinical significance.
Campana D; Pui CH
Blood; 1995 Mar; 85(6):1416-34. PubMed ID: 7888664
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
